Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.

Adar T, Faleck D, Sasidharan S, Cushing K, Borren NZ, Nalagatla N, Ungaro R, Sy W, Owen SC, Patel A, Cohen BL, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2019 Feb 17. doi: 10.1111/apt.15177. [Epub ahead of print]

PMID:
30773667
2.

Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis.

Kelly CR, Ananthakrishnan AN.

JAMA. 2019 Jan 15;321(2):151-152. doi: 10.1001/jama.2018.20397. No abstract available.

PMID:
30644970
3.

Tofacitinib: A Jak of All Trades.

Burke KE, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Jan 6. pii: S1542-3565(19)30017-5. doi: 10.1016/j.cgh.2018.12.044. [Epub ahead of print] No abstract available.

PMID:
30625401
4.

Safety of Biologic Therapy in Older Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis.

Borren NZ, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Jan 4. pii: S1542-3565(19)30005-9. doi: 10.1016/j.cgh.2018.12.032. [Epub ahead of print] Review.

PMID:
30616024
5.

Cancer risk in microscopic colitis: a retrospective cohort study.

Levy A, Borren NZ, Maxner B, Tan W, Bellavance D, Staller K, Chung D, Khalili H, Ananthakrishnan AN.

BMC Gastroenterol. 2019 Jan 5;19(1):1. doi: 10.1186/s12876-018-0926-4.

6.

Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis.

Lee GC, Deery SE, Kunitake H, Hicks CW, Olariu AG, Savitt LR, Ananthakrishnan AN, Ricciardi R, Hodin RA, Bordeianou LG.

Int J Colorectal Dis. 2019 Jan 4. doi: 10.1007/s00384-018-03221-x. [Epub ahead of print]

PMID:
30610435
7.

Fatigue in IBD: epidemiology, pathophysiology and management.

Borren NZ, van der Woude CJ, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2018 Dec 10. doi: 10.1038/s41575-018-0091-9. [Epub ahead of print] Review.

PMID:
30531816
8.

Obesity and Weight Gain Since Early Adulthood are Associated With a Lower Risk of Microscopic Colitis.

Liu PH, Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31334-X. doi: 10.1016/j.cgh.2018.11.057. [Epub ahead of print]

PMID:
30529732
9.

Patient age determines adherence to preventive care measures among patients with ulcerative colitis.

Ghorbani S, Chandradas S, Wayman C, Diamant J, Ananthakrishnan AN, Konijeti GG.

Dig Liver Dis. 2019 Jan;51(1):178-179. doi: 10.1016/j.dld.2018.10.020. Epub 2018 Nov 6. No abstract available.

PMID:
30503295
10.

New approaches along the IBD course: diet, tight control and stem cells.

Ng SC, Ananthakrishnan AN.

Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):82-84. doi: 10.1038/s41575-018-0088-4. No abstract available.

PMID:
30464302
11.

The Gut Microbiome and Digestive Health - A New Frontier.

Ananthakrishnan AN, Singal AG, Chang L.

Clin Gastroenterol Hepatol. 2019 Jan;17(2):215-217. doi: 10.1016/j.cgh.2018.10.040. Epub 2018 Oct 29. No abstract available.

PMID:
30385328
12.

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.

Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Oct;113(10):1524-1529. doi: 10.1038/s41395-018-0239-9. Epub 2018 Sep 28.

PMID:
30267029
13.

Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study.

Borren NZ, Khalili H, Luther J, Colizzo FP, Garber JJ, Ananthakrishnan AN.

Inflamm Bowel Dis. 2018 Sep 11. doi: 10.1093/ibd/izy282. [Epub ahead of print]

PMID:
30204864
14.

Debate session: So what causes inflammatory bowel disease? It's all in the environment.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:24. doi: 10.1111/jgh.14429. No abstract available.

PMID:
30187567
15.

Bugs and drugs: Predicting response to therapy.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:27. doi: 10.1111/jgh.14432. No abstract available.

PMID:
30187562
16.

Making sense of clinical predictors.

Ananthakrishnan AN.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:7-8. doi: 10.1111/jgh.14417. No abstract available.

PMID:
30187548
17.

Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study.

Liu PH, Lebwohl B, Burke KE, Ivey KL, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

Am J Gastroenterol. 2019 Jan;114(1):127-134. doi: 10.1038/s41395-018-0267-5.

PMID:
30181535
18.

Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Burke KE, Ananthakrishnan AN, Lochhead P, Liu PH, Olen O, Ludvigsson JF, Richter JM, Tworoger SS, Chan AT, Khalili H.

Gastroenterology. 2018 Dec;155(6):1764-1775.e2. doi: 10.1053/j.gastro.2018.08.029. Epub 2018 Aug 23.

PMID:
30144433
19.

Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.

Vedamurthy A, Xu L, Luther J, Colizzo F, Garber JJ, Khalili H, Ananthakrishnan AN.

Dig Dis Sci. 2018 Oct;63(10):2740-2746. doi: 10.1007/s10620-018-5176-3. Epub 2018 Jun 27.

PMID:
29951797
20.

Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.

Nalagatla N, Falloon K, Tran G, Borren NZ, Avalos D, Luther J, Colizzo F, Garber J, Khalili H, Melia J, Bohm M, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):502-509.e1. doi: 10.1016/j.cgh.2018.06.031. Epub 2018 Jun 23.

PMID:
29944926
21.

Reply to 'Comment on Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients'.

Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN.

J Crohns Colitis. 2018 Nov 9;12(10):1256. doi: 10.1093/ecco-jcc/jjy095. No abstract available.

PMID:
29939235
22.

Reply.

Ananthakrishnan AN, Ng SC.

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1177. doi: 10.1016/j.cgh.2018.03.015. No abstract available.

PMID:
29914642
23.

Asians have more perianal Crohn disease and ocular manifestations compared with white Americans.

Kochar B, Barnes EL, Herfarth HH, Martin CF, Ananthakrishnan AN, McGovern D, Long M, Sandler RS.

Inflamm Intest Dis. 2018 Mar;2(3):147-153. doi: 10.1159/000484347. Epub 2017 Nov 18.

24.

The Association Between Arthralgia and Vedolizumab Using Natural Language Processing.

Cai T, Lin TC, Bond A, Huang J, Kane-Wanger G, Cagan A, Murphy SN, Ananthakrishnan AN, Liao KP.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2242-2246. doi: 10.1093/ibd/izy127.

25.

The role of diet in the aetiopathogenesis of inflammatory bowel disease.

Khalili H, Chan SSM, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT.

Nat Rev Gastroenterol Hepatol. 2018 Sep;15(9):525-535. doi: 10.1038/s41575-018-0022-9. Review.

PMID:
29789682
26.

IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease.

Simon TG, Van Der Sloot KWJ, Chin SB, Joshi AD, Lochhead P, Ananthakrishnan AN, Xavier R, Chung RT, Khalili H.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2247-2257. doi: 10.1093/ibd/izy128.

PMID:
29788077
27.

Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients.

Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN.

J Crohns Colitis. 2018 May 12. doi: 10.1093/ecco-jcc/jjy064. [Epub ahead of print]

PMID:
29762697
28.

Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis.

Burke KE, Khalili H, Garber JJ, Haritunians T, McGovern DPB, Xavier RJ, Ananthakrishnan AN.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1840-1848. doi: 10.1093/ibd/izy083.

PMID:
29718226
29.

Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases.

Ananthakrishnan AN, Martin C, Kane S, Sandler RS, Long MD.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):203-204. doi: 10.1016/j.cgh.2018.04.001. Epub 2018 Apr 11.

PMID:
29653290
30.

Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.

Luther J, Gala M, Patel SJ, Dave M, Borren N, Xavier RJ, Ananthakrishnan AN.

Dig Dis Sci. 2018 Mar;63(3):738-745. doi: 10.1007/s10620-018-4932-8. Epub 2018 Jan 25.

PMID:
29372477
31.

Smoking is Associated with an Increased Risk of Microscopic Colitis: Results From Two Large Prospective Cohort Studies of US Women.

Burke KE, Ananthakrishnan AN, Lochhead P, Olen O, Ludvigsson JF, Richter JM, Chan AT, Khalili H.

J Crohns Colitis. 2018 Apr 27;12(5):559-567. doi: 10.1093/ecco-jcc/jjy005.

PMID:
29370359
32.

Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.

Schirmer M, Franzosa EA, Lloyd-Price J, McIver LJ, Schwager R, Poon TW, Ananthakrishnan AN, Andrews E, Barron G, Lake K, Prasad M, Sauk J, Stevens B, Wilson RG, Braun J, Denson LA, Kugathasan S, McGovern DPB, Vlamakis H, Xavier RJ, Huttenhower C.

Nat Microbiol. 2018 Mar;3(3):337-346. doi: 10.1038/s41564-017-0089-z. Epub 2018 Jan 8.

33.

Number of retained radiopaque markers on a colonic transit study does not correlate with symptom severity or quality of life in chronic constipation.

Staller K, Barshop K, Ananthakrishnan AN, Kuo B.

Neurogastroenterol Motil. 2018 May;30(5):e13269. doi: 10.1111/nmo.13269. Epub 2017 Dec 18.

PMID:
29251404
34.

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients.

Hall AB, Yassour M, Sauk J, Garner A, Jiang X, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan AN, Kugathasan S, Lander ES, Blainey P, Vlamakis H, Xavier RJ, Huttenhower C.

Genome Med. 2017 Nov 28;9(1):103. doi: 10.1186/s13073-017-0490-5.

35.

Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.

Borren NZ, Conway G, Garber JJ, Khalili H, Budree S, Mallick H, Yajnik V, Xavier RJ, Ananthakrishnan AN.

J Crohns Colitis. 2018 Apr 27;12(5):525-531. doi: 10.1093/ecco-jcc/jjx154.

PMID:
29145572
36.

"Weekend Effect" in Patients With Upper Gastrointestinal Hemorrhage: A Systematic Review and Meta-analysis.

Gupta A, Agarwal R, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Jan;113(1):13-21. doi: 10.1038/ajg.2017.430. Epub 2017 Nov 14. Review.

PMID:
29134968
37.

Enabling phenotypic big data with PheNorm.

Yu S, Ma Y, Gronsbell J, Cai T, Ananthakrishnan AN, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Liao KP, Cai T.

J Am Med Inform Assoc. 2018 Jan 1;25(1):54-60. doi: 10.1093/jamia/ocx111.

38.

Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's disease-Authors' reply.

Feathers A, Swaminath A, Ananthakrishnan AN, Falzon L, Li Ferry S.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1121. doi: 10.1111/apt.14360. No abstract available.

PMID:
29105134
39.

Letter: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease-Authors' reply.

Feathers A, Swaminath A, Ananthakrishnan AN, Falzon L, Li Ferry S.

Aliment Pharmacol Ther. 2017 Nov;46(10):1026-1027. doi: 10.1111/apt.14359. No abstract available.

PMID:
29052855
40.

Environmental triggers in IBD: a review of progress and evidence.

Ananthakrishnan AN, Bernstein CN, Iliopoulos D, Macpherson A, Neurath MF, Ali RAR, Vavricka SR, Fiocchi C.

Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):39-49. doi: 10.1038/nrgastro.2017.136. Epub 2017 Oct 11. Review.

PMID:
29018271
41.

Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.

Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Lochhead P, Richter JM, Chan AT.

Inflamm Bowel Dis. 2017 Nov;23(11):1898-1904. doi: 10.1097/MIB.0000000000001236.

42.

Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis.

Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN.

Aliment Pharmacol Ther. 2017 Nov;46(9):780-789. doi: 10.1111/apt.14291. Epub 2017 Sep 11. Review.

43.

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.

Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):99-105. doi: 10.1016/j.cgh.2017.08.041. Epub 2017 Sep 1.

44.

Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.

Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S.

Aliment Pharmacol Ther. 2017 Oct;46(7):645-656. doi: 10.1111/apt.14253. Epub 2017 Aug 16. Review.

45.

Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.

Khalili H, de Silva PS, Ananthakrishnan AN, Lochhead P, Joshi A, Garber JJ, Richter JR, Sauk J, Chan AT.

Inflamm Bowel Dis. 2017 Jul;23(7):1088-1095. doi: 10.1097/MIB.0000000000001161. Review.

46.

Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies.

Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):190-197.e11. doi: 10.1016/j.cgh.2017.05.047. Epub 2017 Jun 8.

47.

Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.

Borren NZ, Conway G, Tan W, Andrews E, Garber JJ, Yajnik V, Ananthakrishnan AN.

Inflamm Bowel Dis. 2017 Jul;23(7):1234-1239. doi: 10.1097/MIB.0000000000001133.

48.

Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

Ananthakrishnan AN, Luo C, Yajnik V, Khalili H, Garber JJ, Stevens BW, Cleland T, Xavier RJ.

Cell Host Microbe. 2017 May 10;21(5):603-610.e3. doi: 10.1016/j.chom.2017.04.010.

49.

Effect of oral tobacco use and smoking on outcomes of Crohn's disease in India.

Arora U, Ananthakrishnan AN, Kedia S, Bopanna S, Mouli PV, Yadav DP, Makharia GK, Yajnik V, Ahuja V.

J Gastroenterol Hepatol. 2018 Jan;33(1):134-140. doi: 10.1111/jgh.13815.

PMID:
28475826
50.

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS.

Aliment Pharmacol Ther. 2017 Jul;46(2):162-168. doi: 10.1111/apt.14125. Epub 2017 May 3.

Supplemental Content

Loading ...
Support Center